Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Dr Chengxue Helena Qin is the Laboratory Head and National Heart Foundation Future Fellow at Monash University and holds adjunct appointments at the Baker Heart and Diabetes Institute and the University of Melbourne. She is an emerging translational pharmacologist, with combined expertise in rational drug design, medicinal chemistry and pre-clinical models for cardiovascular diseases.

Dr Qin completed her B.BioMed. and PhD at Department of Pharmacology and Therapeutics and School of Chemistry at the University of Melbourne in 2010, before taking up a post-doctoral position at the Baker Heart and Diabetes Institute in 2011, and promoted to the Group Leader in 2017 and awarded with a 5-year Baker Fellowship in the same year. She has recently been recruited to Drug Discovery Biology Theme at Monash Institute of Pharmaceutical Science (Monash Parkville Campus) to establish her independent laboratory, focusing on developing effective and innovative treatments for cardiovascular disease.

Research interests

Her current research focuses on formyl peptide receptors, a group of G-Protein-Coupled-Receptor involved in the regulation and resolution of inflammation. Dr Qin provided the first evidence that selectively engaging beneficial pathways at this receptor have significant therapeutic and translational potential against a range of cardiovascular disease. She has almost 40 publications including those in Nature Communications, Circulation, British Journal of Pharmacology, Journal of Medicinal Chemistry, Pharmacology and Therapeutics etc. She has attracted research funding from NHMRC, National Heart Foundation, Diabetes Australia Research Program, JDRF, CASS Foundation. Her achievements have also been recognized by numerous prestigious awards including National Heart Foundation Future Leader (2020-2023), JDRF Future Leader (2018-2019), Baker Fellow (2018-2022), Best Early Career Scientist at International Society for Heart Research (2017), Ralph Reader Prize (Basic Science, 2016), BPS/ASCEPT Outstanding Young Investigator Award (2015).

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Pharmacology, PhD, Investigation of the mechanisms of the cardioprotective effects of flavonols, University of Melbourne

1 Mar 200620 Aug 2010

Award Date: 20 Aug 2010

Pharmacology, Bachelor of Science (First Class Honours) , Quantitative structure-activity relationships of 3’, 4’- substituted flavonols, University of Melbourne

17 Feb 200531 Dec 2005

Award Date: 31 Dec 2005

Pharmacology, Bachelor of Biomedical Science, Drug Discovery (Pharmacology and Medicinal Chemistry), University of Melbourne

1 Mar 200231 Dec 2004

Award Date: 31 Dec 2004

External positions

Baker Heart and Diabetes Institute

Research area keywords

  • translational pharmacology
  • Cardiovascular disease
  • GPCR biology

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or